Back
Theravance Biopharma, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
68
TBPH
Theravance Biopharma, Inc.
Last Price:
$16.01
Seasonality Move:
-4.75%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and TBPH is experiencing slight buying pressure.
Theravance Biopharma, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.48 | Buy |
| 20-day SMA: | 14.58 | Buy |
| 50-day SMA: | 17.15 | Sell |
| 200-day SMA: | 15.39 | Buy |
| 8-day EMA: | 15.5 | Buy |
| 20-day EMA: | 15.39 | Buy |
| 50-day EMA: | 16.38 | Sell |
| 200-day EMA: | 15.45 | Buy |
Theravance Biopharma, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.27 | Sell |
| Relative Strength Index (14 RSI): | 54.26 | Buy |
| Chaikin Money Flow: | 176787 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.43 - 16.17) | Buy |
| Bollinger Bands (100): | (15.76 - 19.96) | Sell |
Theravance Biopharma, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Theravance Biopharma, Inc. Stock
Is Theravance Biopharma, Inc. Stock a Buy?
-
Theravance Biopharma, Inc. share price is 16.02 while TBPH 8-day simple moving average is 15.48, which is a Buy signal.
-
The stock price of TBPH is 16.02 while Theravance Biopharma, Inc. 20-day SMA is 14.58, which makes it a Buy.
-
Theravance Biopharma, Inc. 50-day simple moving average is 17.15 while TBPH share price is 16.02, making it a Sell technically.
-
TBPH stock price is 16.02 and Theravance Biopharma, Inc. 200-day simple moving average is 15.39, creating a Buy signal.
TBPH Technical Analysis vs Fundamental Analysis
Buy
68
Theravance Biopharma, Inc. (TBPH)
is a Buy
Is Theravance Biopharma, Inc. a Buy or a Sell?
-
Theravance Biopharma, Inc. stock is rated a BuyThe current Theravance Biopharma, Inc. [TBPH] share price is $16.02. The Score for TBPH is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
Theravance Biopharma, Inc. Stock Info
Market Cap:
833.8M
Price in USD:
16.02
Share Volume:
506.8K
Theravance Biopharma, Inc. 52-Week Range
52-Week High:
21.03
52-Week Low:
7.90
Buy
68
Theravance Biopharma, Inc. (TBPH)
is a Buy
Theravance Biopharma, Inc. Share Price Forecast
-
What is the Theravance Biopharma, Inc. stock price today?The Theravance Biopharma, Inc. stock price is 16.02 USD today.
-
Will TBPH stock go up or go down?Theravance Biopharma, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Theravance Biopharma, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Theravance Biopharma, Inc. is not overvalued.
Is Theravance Biopharma, Inc. Stock a Buy?
-
Theravance Biopharma, Inc. share price is 16.02 while TBPH 8-day exponential moving average is 15.50, which is a Buy signal.
-
The stock price of TBPH is 16.02 while Theravance Biopharma, Inc. 20-day EMA is 15.39, which makes it a Buy.
-
Theravance Biopharma, Inc. 50-day exponential moving average is 16.38 while TBPH share price is 16.02, making it a Sell technically.
-
TBPH stock price is 16.02 and Theravance Biopharma, Inc. 200-day simple moving average is 15.45, creating a Buy signal.
Fundamental Analysis of Theravance Biopharma, Inc.
Is Theravance Biopharma, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.28 per share, and a decrease next year of $3.05 per share.
Technical Analysis of Theravance Biopharma, Inc.
Should I short Theravance Biopharma, Inc. stock?
-
TBPH Moving Average Covergence Divergence (MACD) indicator is -0.27, suggesting Theravance Biopharma, Inc. is a Sell
-
Theravance Biopharma, Inc. Relative Strength Index (RSI) is 54.26, which suggest Theravance Biopharma, Inc. is overbought
-
The Bollinger Bands (25) for Theravance Biopharma, Inc. is (13.43 - 16.17), which suggest Theravance Biopharma, Inc. is a Sell
-
The Bollinger Bands (100) for Theravance Biopharma, Inc. is (15.76 - 19.96), which suggest Theravance Biopharma, Inc. is a Sell
* Theravance Biopharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.